Quantification of gait in mitochondrial m.3243A > G patients: a validation study

More than half of the patients harbouring the m.3243A > G mutation were found to have trouble maintaining balance when walking in a recent study by our group. Others demonstrated that these patients had an abnormal gait pattern, as quantified by gait analysis. Gait analysis is an emerging method...

Full description

Saved in:
Bibliographic Details
Published in:Orphanet journal of rare diseases 2017-05, Vol.12 (1), p.91-91, Article 91
Main Authors: Ramakers, Rob, Koene, Saskia, Groothuis, Jan T, de Laat, Paul, Janssen, Mirian Ch, Smeitink, Jan
Format: Article
Language:English
Subjects:
Adults
Ataxia
Balance
Gait
Genetic research
Health care
m.3243A > G
Medical research
MELAS
Mitochondria
Mitochondrial biogenesis
Mitochondrial disease
Mutation
Neuromuscular diseases
Older people
Patients
Posture
Quality of life
Rare diseases
Stroke
Therapeutic applications
Trial
Urine
Walking
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:More than half of the patients harbouring the m.3243A > G mutation were found to have trouble maintaining balance when walking in a recent study by our group. Others demonstrated that these patients had an abnormal gait pattern, as quantified by gait analysis. Gait analysis is an emerging method to quantify subtle changes in walking pattern, also during therapeutic interventions. Therefore, we aimed to test the reliability and reproducibility of gait analysis and select the most suitable protocol for this group of patients using a GAITRite electronic walkway. Four different protocols were tested: normal walking, dual task, post exercise and after a ten minutes of rest. In total 36 patients with the m.3243A > G mutation and 50 healthy controls were enrolled in this study. Overall high intra class correlation coefficients were found in all experimental conditions for both patients and healthy controls indicating good reproducibility. Marked differences in gait between patients and controls were observed and were in line with the only available exploratory study performed. There was a good correlation between both the overall NMDAS score, NMDAS subscale scores, both markers for disease severity, and specific gait parameters. The observed reliability of the test makes GAITRite a suitable instrument for intervention studies in patients with mitochondrial disease.
ISSN:1750-1172
1750-1172
DOI:10.1186/s13023-017-0644-y